|
|
Multiple SclerosisPage 8
Immunotherapy
As evidence of immune system involvement in the development of MS has grown, trials of various new treatments to alter or suppress immune response are being conducted. Most of these therapies are, at this time, still considered experimental.
Results of recent clinical trials have shown that immunosuppressive agents and techniques can positively (if temporarily) affect the course of MS - however, toxic side effects often preclude their widespread use. In addition, generalized immunosuppression leaves the patient open to a variety of viral, bacterial, and fungal infections.
Over the years, MS investigators have studied a number of immunosuppressant treatments. One such treatment, Novantrone (mitoxantrone), was approved by the FDA for the treatment of advanced or chronic (lasting a long time) MS. Other therapies being studied are cyclosporine (Sandimmune), cyclophosphamide (Cytoxan), methotrexate, azathioprine (Imuran), and total lymphoid irradiation (a process whereby the MS patient's lymph nodes are irradiated with x-rays in small doses over a few weeks to destroy lymphoid tissue, which is actively involved in tissue destruction in autoimmune disease. Inconclusive and / or contradictory results of these trials, combined with the therapies' potentially dangerous side effects, dictate that further research is necessary to determine what, if any, role they should play in the management of MS. Studies are also being conducted with the immune system modulating drug cladribine (Leustatin).
Another potential treatment for MS is monoclonal antibodies, which are identical, laboratory-produced antibodies that are highly specific for a single antigen. They are injected into the patient in the hope that they will alter the patient's immune response. One monoclonal antibody, natalizumab (Tysabri), was shown in clinical trials to significantly reduce the frequency of attacks in people with relapsing forms of MS and was approved for marketing by the U.S. Food and Drug Administration (FDA) in 2004. However, in 2005 the drug's manufacturer voluntarily suspended marketing of the drug after several reports of significant adverse events. In 2006, the FDA again approved sale of the drug for MS but under strict treatment guidelines involving infusion centers where patients can be monitored by specially trained physicians.
Another experimental treatment for MS is plasma exchange, or plasmapheresis. Plasmapheresis is a procedure in which blood is removed from the patient and the blood plasma is separated from other blood substances that may contain antibodies and other immunologically active products. These other blood substances are discarded and the plasma is then transfused back into the patient. Because its worth as a treatment for MS has not yet been proven, this experimental treatment remains at the stage of clinical testing.
Bone marrow transplantation (a procedure in which bone marrow from a healthy donor is infused into patients who have undergone drug or radiation therapy to suppress their immune system so they will not reject the donated marrow) and injections of venom from honey bees are also being studied. Each of these therapies carries the risk of potentially severe side effects.
Page 1 What is Multiple Sclerosis?
Page 2 The Immune System
Page 3 Genetics
Page 4 What is the Course of MS?
Page 5 Symptoms of MS
Page 6 How is MS Diagnosed?
Page 7 Can MS be Treated?
Page 8 Immunotherapy
Page 9 Therapy
Page 10 Are Any MS Symptoms Treatable?
Page 11 Recent Advances Made in MS Research
References:
NIH Publication No. 96-75 - September 1996 - www.ninds.nih.gov/disorders/multiple_sclerosis/detail_multiple_sclerosis.htm
This summary is a general overview about the topic discussed and does not include all the facts, or include everything there is to know about any medicine and/or products mentioned. Do not use any medicine and/or products without first talking to your doctor. Possible side effects of medications, other than those listed, may occur. Other brand names or generic forms of this medicine may also be available. If you have questions or concerns, or want more information, your doctor or pharmacist has the complete prescribing information about this medicine and possible drug interactions. Full Disclaimer
|
Nexium - Esomeprazole
Aciphex - Rabeprazole
Prevacid - Lansoprazole
Prilosec - Omeprazole
Prilosec OCT
Protonix - Pantoprazole
| GastroEsophageal Reflux Disease
|
GERD
Causes of GERD
Diet for GERD
Infant GERD
Children 1 - 11 Years Old
Medication for GERD
Symptoms of GERD
GERD Surgery
GERD Treatment
Heartburn
Causes of Heartburn
Symptoms of Heartburn
Heartburn Medications
Heartburn Remedy
Can Flatulence Be Controlled
Lump In Throat
Proton Pump Inhibitors
Remedies for GERD
Acne
Hair Removal
HGH
|